Margaret A. Tempero, MD, on Pancreatic Cancer: Active Systemic Treatment

2017 NCCN Annual Conference
Tweet this page

Margaret A. Tempero, MD, of the UCSF Helen Diller Family Comprehensive Cancer Center, discusses the evidence for using neoadjuvant and adjuvant systemic therapies in resectable and borderline resectable pancreatic cancer.

Advertisement

Advertisement



Advertisement

click me